Influence of cell cycle checkpoints and p53 function on the toxicity of temozolomide in human pancreatic cancer cells

Seema Gupta, Sabapathi Sathishkumar, Mansoor M. Ahmed

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Though an increased efficacy of carmustine and temozolomide (TMZ) has been demonstrated by inactivation of O6-methylguanine-DNA methyltransferase (MGMT) with O6-benzyl-guanine (BG) in human pancreatic tumors refractive to alkylating agents, the regulatory mechanisms have not been explored. Methods: The effects of TMZ and BG on apoptosis, cell growth, the mitotic index, cell cycle distribution, and protein expression were studied by TUNEL, cell counting, flow cytometry, and Western blot analysis, respectively. Results: The wt-p53 human pancreatic tumor cell line Capan-2 and p53-efficient mouse embryonic fibroblasts (MEFs) were more responsive to treatment with TMZ + BG than mutant p53 Capan-1 and p53-null MEFs. S phase delay with a subsequent G2/M arrest was observed in Capans in response to BG + TMZ. The G1-to-S transition delay in Capan-2 was associated with p53-dependent apoptosis and was distinctly different from the presumed mismatch repair (MMR) killing operative during the G2/M arrest. The effect of p53 on BG + TMZ toxicity was supported by a marked change in apoptosis when p53 function was restored/inactivated. There was an early induction of MMR proteins in p53-efficient lines. Conclusion: p53 provokes a classic proapoptotic response by delaying G1-to-S progression, but it may also facilitate cell killing by enhancing MMR-related cell cycle arrest and cell death.

Original languageEnglish (US)
Pages (from-to)565-579
Number of pages15
JournalPancreatology
Volume10
Issue number5
DOIs
StatePublished - Dec 2010
Externally publishedYes

Fingerprint

temozolomide
Guanine
Cell Cycle Checkpoints
Pancreatic Neoplasms
DNA Mismatch Repair
Apoptosis
Fibroblasts
Carmustine
Cell Cycle Proteins
Mitotic Index
Alkylating Agents
In Situ Nick-End Labeling
Methyltransferases
Tumor Cell Line
S Phase
Flow Cytometry
Cell Death
Western Blotting
DNA

Keywords

  • Cell cycle arrest
  • Mismatch repair
  • O-Benzylguanine
  • p21
  • p53
  • Pancreatic cancer
  • Temozolomide

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Hepatology

Cite this

Influence of cell cycle checkpoints and p53 function on the toxicity of temozolomide in human pancreatic cancer cells. / Gupta, Seema; Sathishkumar, Sabapathi; Ahmed, Mansoor M.

In: Pancreatology, Vol. 10, No. 5, 12.2010, p. 565-579.

Research output: Contribution to journalArticle

Gupta, Seema ; Sathishkumar, Sabapathi ; Ahmed, Mansoor M. / Influence of cell cycle checkpoints and p53 function on the toxicity of temozolomide in human pancreatic cancer cells. In: Pancreatology. 2010 ; Vol. 10, No. 5. pp. 565-579.
@article{43dca32dab644c20a08f68e8298974c5,
title = "Influence of cell cycle checkpoints and p53 function on the toxicity of temozolomide in human pancreatic cancer cells",
abstract = "Background: Though an increased efficacy of carmustine and temozolomide (TMZ) has been demonstrated by inactivation of O6-methylguanine-DNA methyltransferase (MGMT) with O6-benzyl-guanine (BG) in human pancreatic tumors refractive to alkylating agents, the regulatory mechanisms have not been explored. Methods: The effects of TMZ and BG on apoptosis, cell growth, the mitotic index, cell cycle distribution, and protein expression were studied by TUNEL, cell counting, flow cytometry, and Western blot analysis, respectively. Results: The wt-p53 human pancreatic tumor cell line Capan-2 and p53-efficient mouse embryonic fibroblasts (MEFs) were more responsive to treatment with TMZ + BG than mutant p53 Capan-1 and p53-null MEFs. S phase delay with a subsequent G2/M arrest was observed in Capans in response to BG + TMZ. The G1-to-S transition delay in Capan-2 was associated with p53-dependent apoptosis and was distinctly different from the presumed mismatch repair (MMR) killing operative during the G2/M arrest. The effect of p53 on BG + TMZ toxicity was supported by a marked change in apoptosis when p53 function was restored/inactivated. There was an early induction of MMR proteins in p53-efficient lines. Conclusion: p53 provokes a classic proapoptotic response by delaying G1-to-S progression, but it may also facilitate cell killing by enhancing MMR-related cell cycle arrest and cell death.",
keywords = "Cell cycle arrest, Mismatch repair, O-Benzylguanine, p21, p53, Pancreatic cancer, Temozolomide",
author = "Seema Gupta and Sabapathi Sathishkumar and Ahmed, {Mansoor M.}",
year = "2010",
month = "12",
doi = "10.1159/000317254",
language = "English (US)",
volume = "10",
pages = "565--579",
journal = "Pancreatology",
issn = "1424-3903",
publisher = "S. Karger AG",
number = "5",

}

TY - JOUR

T1 - Influence of cell cycle checkpoints and p53 function on the toxicity of temozolomide in human pancreatic cancer cells

AU - Gupta, Seema

AU - Sathishkumar, Sabapathi

AU - Ahmed, Mansoor M.

PY - 2010/12

Y1 - 2010/12

N2 - Background: Though an increased efficacy of carmustine and temozolomide (TMZ) has been demonstrated by inactivation of O6-methylguanine-DNA methyltransferase (MGMT) with O6-benzyl-guanine (BG) in human pancreatic tumors refractive to alkylating agents, the regulatory mechanisms have not been explored. Methods: The effects of TMZ and BG on apoptosis, cell growth, the mitotic index, cell cycle distribution, and protein expression were studied by TUNEL, cell counting, flow cytometry, and Western blot analysis, respectively. Results: The wt-p53 human pancreatic tumor cell line Capan-2 and p53-efficient mouse embryonic fibroblasts (MEFs) were more responsive to treatment with TMZ + BG than mutant p53 Capan-1 and p53-null MEFs. S phase delay with a subsequent G2/M arrest was observed in Capans in response to BG + TMZ. The G1-to-S transition delay in Capan-2 was associated with p53-dependent apoptosis and was distinctly different from the presumed mismatch repair (MMR) killing operative during the G2/M arrest. The effect of p53 on BG + TMZ toxicity was supported by a marked change in apoptosis when p53 function was restored/inactivated. There was an early induction of MMR proteins in p53-efficient lines. Conclusion: p53 provokes a classic proapoptotic response by delaying G1-to-S progression, but it may also facilitate cell killing by enhancing MMR-related cell cycle arrest and cell death.

AB - Background: Though an increased efficacy of carmustine and temozolomide (TMZ) has been demonstrated by inactivation of O6-methylguanine-DNA methyltransferase (MGMT) with O6-benzyl-guanine (BG) in human pancreatic tumors refractive to alkylating agents, the regulatory mechanisms have not been explored. Methods: The effects of TMZ and BG on apoptosis, cell growth, the mitotic index, cell cycle distribution, and protein expression were studied by TUNEL, cell counting, flow cytometry, and Western blot analysis, respectively. Results: The wt-p53 human pancreatic tumor cell line Capan-2 and p53-efficient mouse embryonic fibroblasts (MEFs) were more responsive to treatment with TMZ + BG than mutant p53 Capan-1 and p53-null MEFs. S phase delay with a subsequent G2/M arrest was observed in Capans in response to BG + TMZ. The G1-to-S transition delay in Capan-2 was associated with p53-dependent apoptosis and was distinctly different from the presumed mismatch repair (MMR) killing operative during the G2/M arrest. The effect of p53 on BG + TMZ toxicity was supported by a marked change in apoptosis when p53 function was restored/inactivated. There was an early induction of MMR proteins in p53-efficient lines. Conclusion: p53 provokes a classic proapoptotic response by delaying G1-to-S progression, but it may also facilitate cell killing by enhancing MMR-related cell cycle arrest and cell death.

KW - Cell cycle arrest

KW - Mismatch repair

KW - O-Benzylguanine

KW - p21

KW - p53

KW - Pancreatic cancer

KW - Temozolomide

UR - http://www.scopus.com/inward/record.url?scp=77958514284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958514284&partnerID=8YFLogxK

U2 - 10.1159/000317254

DO - 10.1159/000317254

M3 - Article

C2 - 20980775

AN - SCOPUS:77958514284

VL - 10

SP - 565

EP - 579

JO - Pancreatology

JF - Pancreatology

SN - 1424-3903

IS - 5

ER -